217 related articles for article (PubMed ID: 9342182)
1. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination.
Mateyak MK; Obaya AJ; Adachi S; Sedivy JM
Cell Growth Differ; 1997 Oct; 8(10):1039-48. PubMed ID: 9342182
[TBL] [Abstract][Full Text] [Related]
2. Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosis.
Xiao Q; Claassen G; Shi J; Adachi S; Sedivy J; Hann SR
Genes Dev; 1998 Dec; 12(24):3803-8. PubMed ID: 9869633
[TBL] [Abstract][Full Text] [Related]
3. MYC: there is more to it than cancer.
Zacarías-Fluck MF; Soucek L; Whitfield JR
Front Cell Dev Biol; 2024; 12():1342872. PubMed ID: 38510176
[TBL] [Abstract][Full Text] [Related]
4. Isoform-Directed Control of c-Myc Functions: Understanding the Balance from Proliferation to Growth Arrest.
Kubickova A; De Sanctis JB; Hajduch M
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139353
[TBL] [Abstract][Full Text] [Related]
5. MYC function and regulation in physiological perspective.
Jha RK; Kouzine F; Levens D
Front Cell Dev Biol; 2023; 11():1268275. PubMed ID: 37941901
[TBL] [Abstract][Full Text] [Related]
6. MYC-an emerging player in mitochondrial diseases.
Purhonen J; Klefström J; Kallijärvi J
Front Cell Dev Biol; 2023; 11():1257651. PubMed ID: 37731815
[TBL] [Abstract][Full Text] [Related]
7. Lessons in aging from Myc knockout mouse models.
Prochownik EV; Wang H
Front Cell Dev Biol; 2023; 11():1244321. PubMed ID: 37621775
[TBL] [Abstract][Full Text] [Related]
8. Premature aging and reduced cancer incidence associated with near-complete body-wide Myc inactivation.
Wang H; Lu J; Stevens T; Roberts A; Mandel J; Avula R; Ma B; Wu Y; Wang J; Land CV; Finkel T; Vockley JE; Airik M; Airik R; Muzumdar R; Gong Z; Torbenson MS; Prochownik EV
Cell Rep; 2023 Aug; 42(8):112830. PubMed ID: 37481724
[TBL] [Abstract][Full Text] [Related]
9. MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products.
Chan KI; Zhang S; Li G; Xu Y; Cui L; Wang Y; Su H; Tan W; Zhong Z
Aging Dis; 2024 Apr; 15(2):640-697. PubMed ID: 37450923
[TBL] [Abstract][Full Text] [Related]
10. MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner.
Castell A; Yan Q; Fawkner K; Bazzar W; Zhang F; Wickström M; Alzrigat M; Franco M; Krona C; Cameron DP; Dyberg C; Olsen TK; Verschut V; Schmidt L; Lim SY; Mahmoud L; Hydbring P; Lehmann S; Baranello L; Nelander S; Johnsen JI; Larsson LG
Cancer Res Commun; 2022 Mar; 2(3):182-201. PubMed ID: 36874405
[TBL] [Abstract][Full Text] [Related]
11. Disruption of Multiple Overlapping Functions Following Stepwise Inactivation of the Extended Myc Network.
Wang H; Stevens T; Lu J; Airik M; Airik R; Prochownik EV
Cells; 2022 Dec; 11(24):. PubMed ID: 36552851
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Normal and Neoplastic Proliferation and Metabolism by the Extended Myc Network.
Prochownik EV
Cells; 2022 Dec; 11(24):. PubMed ID: 36552737
[TBL] [Abstract][Full Text] [Related]
13. Reversible Myc hypomorphism identifies a key Myc-dependency in early cancer evolution.
Sodir NM; Pellegrinet L; Kortlever RM; Campos T; Kwon YW; Kim S; Garcia D; Perfetto A; Anastasiou P; Swigart LB; Arends MJ; Littlewood TD; Evan GI
Nat Commun; 2022 Nov; 13(1):6782. PubMed ID: 36351945
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of the NIH3T3 Fibroblast Cell Line.
Rahimi AM; Cai M; Hoyer-Fender S
Cells; 2022 Aug; 11(17):. PubMed ID: 36078083
[TBL] [Abstract][Full Text] [Related]
15. MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.
Ahmadi SE; Rahimi S; Zarandi B; Chegeni R; Safa M
J Hematol Oncol; 2021 Aug; 14(1):121. PubMed ID: 34372899
[TBL] [Abstract][Full Text] [Related]
16. Genome-Wide Analysis of c-MYC-Regulated mRNAs and miRNAs and c-MYC DNA-Binding by Next-Generation Sequencing.
Jackstadt R; Kaller M; Menssen A; Hermeking H
Methods Mol Biol; 2021; 2318():119-160. PubMed ID: 34019289
[TBL] [Abstract][Full Text] [Related]
17. Co-Operativity between MYC and BCL-2 Pro-Survival Proteins in Cancer.
Fairlie WD; Lee EF
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799592
[TBL] [Abstract][Full Text] [Related]
18. Integrated requirement of non-specific and sequence-specific DNA binding in Myc-driven transcription.
Pellanda P; Dalsass M; Filipuzzi M; Loffreda A; Verrecchia A; Castillo Cano V; Thabussot H; Doni M; Morelli MJ; Soucek L; Kress T; Mazza D; Mapelli M; Beaulieu ME; Amati B; Sabò A
EMBO J; 2021 May; 40(10):e105464. PubMed ID: 33792944
[TBL] [Abstract][Full Text] [Related]
19. FUBP1 and FUBP2 enforce distinct epigenetic setpoints for MYC expression in primary single murine cells.
Zheng Y; Dubois W; Benham C; Batchelor E; Levens D
Commun Biol; 2020 Oct; 3(1):545. PubMed ID: 33005010
[TBL] [Abstract][Full Text] [Related]
20. Target gene-independent functions of MYC oncoproteins.
Baluapuri A; Wolf E; Eilers M
Nat Rev Mol Cell Biol; 2020 May; 21(5):255-267. PubMed ID: 32071436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
